And the company posted a tweet in this regard, saying, “We are delighted to inform you that we have received approval from the United States Food and Drug Administration to initiate the first clinical trial.”
“This is the result of the incredible work the Neuralink team has done working closely with the U.S. Food and Drug Administration and represents an important first step that will one day allow our technology to help many more people.” , she added.
Musk previously expected, on at least four occasions since 2019, Neuralink, which was founded in 2016, to obtain the necessary approvals to begin experiments with its microchip on humans to treat certain medical conditions such as paralysis. and blindness.
The U.S. Food and Drug Administration has previously attributed the reasons for its rejection of the experiment to the existence of concerns such as the danger of the built-in lithium battery, as it stressed the need to conduct tests on animals to prove that the battery is not subject to malfunction and can not damage brain tissue.
Management concerns also include the fine wires the company uses in the chip, which increase the risk of encephalitis, hampering its functions and rupturing blood vessels, according to British newspaper The Guardian.
The administration also asked about the chip’s high temperature and the extent to which it could be removed from the brain without causing harm.
“Neuralink” says it aims, through the chip and the technology that runs on it, to help people who suffer from paralysis, in order to restore movement in the best of cases or control computers and cell phones to live. in an autonomous way.
Musk believes the strategic goal is to one day achieve a treatment for brain disorders with chips, in addition to brain and spinal cord damage, and to be able to restore sight to people even if they were born without it.
Musk, who has expressed his confidence in the breakthrough technology by saying he is ready to implant it in his children, hopes that the microchip’s role will expand to be used in healthy people as well, and that it will contribute to the treatment of obesity, autism and depression.
Read the Latest World News Today on The Eastern Herald.
